{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,22]],"date-time":"2026-02-22T11:51:50Z","timestamp":1771761110470,"version":"3.50.1"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T00:00:00Z","timestamp":1688515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T00:00:00Z","timestamp":1688515200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Patient Rep Outcomes"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Dry eye disease (DED), Meibomian gland dysfunction (MGD), and Sj\u00f6gren\u2019s syndrome dry eye disease (SS-DED) are eye dryness conditions that show significant overlap in various symptoms of ocular discomfort. The aim of this study was to qualitatively explore the patient experience and evaluate content validity of the newly developed Dry Eye Disease Questionnaire (DED-Q).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Semi-structured interviews were conducted with 61 US adults who reported experiencing ocular symptoms due to their physician-confirmed primary diagnosis of DED (n\u2009=\u200921), MGD (n\u2009=\u200920), or SS-DED (n\u2009=\u200920). The open-ended concept-elicitation phase was followed by cognitive debriefing (CD) of the DED-Q to evaluate participants\u2019 understanding and relevance of the instructions, items, response options, and recall periods. Interviews were also conducted with eight specialist healthcare professionals to assess clinical relevance of the concepts included. Verbatim interview transcripts were analyzed using thematic analysis in ATLAS.ti v8 software.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>A total of 29 symptoms and 14 impacts on quality of life were reported across participant interviews. Primary ocular symptoms reported included eye dryness (n\u2009=\u200961\/61; 100%), eye irritation (n\u2009=\u200955\/61; 90%), eye itch (n\u2009=\u200954\/61; 89%), burning sensation (n\u2009=\u200952\/61; 85%), and foreign body sensation (n\u2009=\u200951\/61; 84%). The most impacted aspects of daily life were using digital screens (n\u2009=\u200946\/61; 75%), driving (n\u2009=\u200945\/61; 74%), working (n\u2009=\u200939\/61; 64%), and reading (n\u2009=\u200937\/61; 61%). CD findings showed most participants had good understanding of DED-Q items and confirmed most concepts were relevant to the lived experience of their condition. Aside from few minor changes to the items and examples to facilitate more accurate interpretation, the proposed instruction wording was modified for various symptom and impact modules to encourage participants to focus only on dry eye vision problems.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>This research identified multiple prevalent symptoms and impacts of DED, MGD, and SS-DED, most of which were similar across the conditions. The DED-Q was confirmed to be a content-valid PRO measure suitable for use in clinical studies to assess the patient experience of DED, MGD, and SS-DED. Future work will focus on evaluating the psychometric properties of the DED-Q for use as an efficacy endpoint in clinical trials.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s41687-023-00608-5","type":"journal-article","created":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T12:01:50Z","timestamp":1688558510000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Development and content validity assessment of the Dry Eye Disease Questionnaire in patients with dry eye disease, meibomian gland dysfunction, and Sj\u00f6gren\u2019s syndrome dry eye disease"],"prefix":"10.1186","volume":"7","author":[{"given":"Brigitte","family":"Sloesen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alyson","family":"Young","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katie","family":"Forde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicola","family":"Hodson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Bentley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Oonagh","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christel","family":"Naujoks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Garima","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,7,5]]},"reference":[{"issue":"2","key":"608_CR1","doi-asserted-by":"publisher","first-page":"75","DOI":"10.1016\/S1542-0124(12)70081-2","volume":"5","author":"DEWS Definition and Classification Subcommittee of the International Dry Eye Workshop","year":"2007","unstructured":"DEWS Definition and Classification Subcommittee of the International Dry Eye Workshop (2007) The definition and classification of dry eye disease: report of the definition and classification subcommittee. Ocul Surf 5(2):75\u201392","journal-title":"Ocul Surf"},{"issue":"3","key":"608_CR2","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.jtos.2017.05.008","volume":"15","author":"JP Craig","year":"2017","unstructured":"Craig JP, Nichols KK, Akpek EK, Caffery B, Dua HS, Joo CK, Liu Z, Nelson JD, Nichols JJ, Tsubota K, Stapleton F (2017) TFOS DEWS II definition and classification report. Ocul Surf 15(3):276\u2013283","journal-title":"Ocul Surf"},{"issue":"4","key":"608_CR3","first-page":"221","volume":"21","author":"MA Lemp","year":"1995","unstructured":"Lemp MA (1995) Report of the national eye institute\/industry workshop on clinical trials in dry eyes. Clao J 21(4):221\u2013232","journal-title":"Clao J"},{"issue":"4","key":"608_CR4","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/j.preteyeres.2004.04.003","volume":"23","author":"ME Johnson","year":"2004","unstructured":"Johnson ME, Murphy PJ (2004) Changes in the tear film and ocular surface from dry eye syndrome. Prog Retin Eye Res 23(4):449\u2013474","journal-title":"Prog Retin Eye Res"},{"issue":"2","key":"608_CR5","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/S1542-0124(12)70082-4","volume":"5","author":"Epidemiology Subcommittee of the International Dry Eye WorkShop","year":"2007","unstructured":"Epidemiology Subcommittee of the International Dry Eye WorkShop (2007) The epidemiology of dry eye disease. Ocul Surf 5(2):93\u2013107","journal-title":"Ocul Surf"},{"issue":"10, Supplement","key":"608_CR6","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1016\/j.ophtha.2012.06.064","volume":"119","author":"GN Foulks","year":"2012","unstructured":"Foulks GN, Nichols KK, Bron AJ, Holland EJ, McDonald MB, Nelson JD (2012) Improving awareness, identification, and management of meibomian gland dysfunction. Ophthalmology 119(10, Supplement):S1-12","journal-title":"Ophthalmology"},{"issue":"4","key":"608_CR7","first-page":"1930","volume":"52","author":"JD Nelson","year":"2011","unstructured":"Nelson JD, Shimazaki J, Benitez-del-Castillo JM, Craig JP, McCulley JP, Den S, Foulks G (2011) The international workshop on meibomian gland dysfunction: report of the definition and classification subcommittee. IVOS 52(4):1930\u20131937","journal-title":"IVOS"},{"issue":"4","key":"608_CR8","first-page":"1994","volume":"52","author":"DA Schaumberg","year":"2011","unstructured":"Schaumberg DA, Nichols JJ, Papas EB, Tong L, Uchino M, Nichols KK (2011) The international workshop on meibomian gland dysfunction: report of the subcommittee on the epidemiology of, and associated risk factors for. MGD IOVS 52(4):1994\u20132005","journal-title":"MGD IOVS"},{"issue":"2","key":"608_CR9","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1111\/j.1600-0722.2004.00183.x","volume":"113","author":"N Delaleu","year":"2005","unstructured":"Delaleu N, Jonsson R, Koller MM (2005) Sj\u00f6gren\u2019s syndrome. Eur J Oral Sci 113(2):101\u2013113","journal-title":"Eur J Oral Sci"},{"issue":"1","key":"608_CR10","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.ajo.2007.03.055","volume":"144","author":"E Goto","year":"2007","unstructured":"Goto E, Matsumoto Y, Kamoi M, Endo K, Ishida R, Dogru M, Kaido M, Kojima T, Tsubota K (2007) Tear evaporation rates in Sj\u00f6gren syndrome and non-Sj\u00f6gren dry eye patients. Am J Ophthalmol 144(1):81\u201385","journal-title":"Am J Ophthalmol"},{"issue":"12","key":"608_CR11","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1136\/bjophthalmol-2012-301767","volume":"96","author":"MS Liew","year":"2012","unstructured":"Liew MS, Zhang M, Kim E, Akpek EK (2012) Prevalence and predictors of Sjogren\u2019s syndrome in a prospective cohort of patients with aqueous-deficient dry eye. Br J Ophthalmol 96(12):1498\u20131503","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"608_CR12","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jtos.2017.05.003","volume":"15","author":"F Stapleton","year":"2017","unstructured":"Stapleton F, Alves M, Bunya VY, Jalbert I, Lekhanont K, Malet F, Na KS, Schaumberg D, Uchino M, Vehof J, Viso E, Vitale S, Jones L (2017) TFOS DEWS II epidemiology report. Ocul Surf 15(3):334\u2013365","journal-title":"Ocul Surf"},{"key":"608_CR13","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1016\/j.ajo.2017.06.033","volume":"182","author":"KF Farrand","year":"2017","unstructured":"Farrand KF, Fridman M, Stillman I\u00d6, Schaumberg DA (2017) Prevalence of diagnosed dry eye disease in the United States among adults aged 18 years and older. Am J Ophthalmol 182:90\u201398","journal-title":"Am J Ophthalmol"},{"issue":"3","key":"608_CR14","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1136\/bjophthalmol-2015-307415","volume":"100","author":"C Baudouin","year":"2016","unstructured":"Baudouin C, Messmer EM, Aragona P, Geerling G, Akova YA, Ben\u00edtez-del-Castillo J, Boboridis KG, Merayo-Lloves J, Rolando M, Labetoulle M (2016) Revisiting the vicious circle of dry eye disease: a focus on the pathophysiology of meibomian gland dysfunction. Br J Ophthalmol 100(3):300\u2013306","journal-title":"Br J Ophthalmol"},{"issue":"11","key":"608_CR15","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1097\/ICO.0b013e31823f0977","volume":"31","author":"JJ Siak","year":"2012","unstructured":"Siak JJ, Tong L, Wong WL, Cajucom-Uy H, Rosman M, Saw SM, Wong TY (2012) Prevalence and risk factors of meibomian gland dysfunction: the Singapore Malay eye study. Cornea 31(11):1223\u20131228","journal-title":"Cornea"},{"issue":"6","key":"608_CR16","first-page":"2601","volume":"53","author":"E Viso","year":"2012","unstructured":"Viso E, Rodr\u00edguez-Ares MT, Abelenda D, Oubi\u00f1a B, Gude F (2012) Prevalence of asymptomatic and symptomatic meibomian gland dysfunction in the general population of Spain. IOVS 53(6):2601\u20132606","journal-title":"IOVS"},{"issue":"3","key":"608_CR17","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1016\/j.jtos.2016.04.005","volume":"14","author":"S Barabino","year":"2016","unstructured":"Barabino S, Labetoulle M, Rolando M, Messmer EM (2016) Understanding symptoms and quality of life in patients with dry eye syndrome. Ocul Surf 14(3):365\u2013376","journal-title":"Ocul Surf"},{"issue":"10","key":"608_CR18","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1136\/bjophthalmol-2018-312581","volume":"103","author":"M Labetoulle","year":"2019","unstructured":"Labetoulle M, Bourcier T, Doan S (2019) Classifying signs and symptoms of dry eye disease according to underlying mechanism via the Delphi method: the DIDACTIC study. Br J Ophthalmol 103(10):1475\u20131480","journal-title":"Br J Ophthalmol"},{"issue":"3","key":"608_CR19","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1002\/art.21990","volume":"55","author":"J Champey","year":"2006","unstructured":"Champey J, Corruble E, Gottenberg JE, Buhl C, Meyer T, Caudmont C, Berge E, Pellet J, Hardy P, Mariette X (2006) Quality of life and psychological status in patients with primary Sj\u00f6gren\u2019s syndrome and sicca symptoms without autoimmune features. Arthritis Rheum 55(3):451\u2013457","journal-title":"Arthritis Rheum"},{"issue":"4","key":"608_CR20","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1097\/ICU.0b013e32833a8c15","volume":"21","author":"NJ Friedman","year":"2010","unstructured":"Friedman NJ (2010) Impact of dry eye disease and treatment on quality of life. Curr Opin Ophthalmol 21(4):310\u2013316","journal-title":"Curr Opin Ophthalmol"},{"issue":"6","key":"608_CR21","doi-asserted-by":"publisher","first-page":"535","DOI":"10.1016\/j.cct.2004.09.003","volume":"25","author":"RJ Willke","year":"2004","unstructured":"Willke RJ, Burke LB, Erickson P (2004) Measuring treatment impact: a review of patient-reported outcomes and other efficacy endpoints in approved product labels. Control Clin Trials 25(6):535\u2013552","journal-title":"Control Clin Trials"},{"key":"608_CR22","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.f167","volume":"346","author":"N Black","year":"2013","unstructured":"Black N (2013) Patient reported outcome measures could help transform healthcare. BMJ 346:f167","journal-title":"BMJ"},{"key":"608_CR23","unstructured":"US Food and Drug Administration (2009) Guidance for industry-Patient-reported outcome measures: use in medical product development to support labeling claims. FDA, Maryland"},{"key":"608_CR24","unstructured":"US Food and Drug Administration (2018) Patient-Focused Drug Development: Collecting Comprehensive and Representative Input. Guidance for Industry, Food and Drug Administration staff, and other stakeholders. FDA, Maryland"},{"key":"608_CR25","unstructured":"US Food and Drug Administration (2022) Patient-Focused Drug Development: Methods to Identify What Is Important to Patients, Guidance for Industry, Food and Drug Administration staff, and other stakeholders. FDA, Maryland"},{"key":"608_CR26","unstructured":"US Food and Drug Administration (2022) Patient-Focused Drug Development: Selecting, Developing, or Modifying Fit-forPurpose Clinical Outcome Assessments: Guidance for Industry, Food and Drug Administration staff, and other stakeholders. FDA, Maryland"},{"issue":"1","key":"608_CR27","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1016\/S1542-0124(12)70053-8","volume":"5","author":"DA Schaumberg","year":"2007","unstructured":"Schaumberg DA, Gulati A, Mathers WD, Clinch T, Lemp MA, Nelson JD, Foulks GN, Dana R (2007) Development and validation of a short global dry eye symptom index. Ocul Surf 5(1):50\u201357","journal-title":"Ocul Surf"},{"issue":"9","key":"608_CR28","doi-asserted-by":"publisher","first-page":"1204","DOI":"10.1097\/ICO.0b013e318294b0c0","volume":"32","author":"W Ngo","year":"2013","unstructured":"Ngo W, Situ P, Keir N, Korb D, Blackie C, Simpson T (2013) Psychometric properties and validation of the Standard Patient Evaluation of Eye Dryness questionnaire. Cornea 32(9):1204\u20131210","journal-title":"Cornea"},{"issue":"10","key":"608_CR29","first-page":"4451","volume":"48","author":"ME Johnson","year":"2007","unstructured":"Johnson ME, Murphy PJ (2007) Measurement of ocular surface irritation on a linear interval scale with the ocular comfort index. IOVS 48(10):4451\u20134458","journal-title":"IOVS"},{"issue":"2","key":"608_CR30","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.clae.2009.12.010","volume":"33","author":"RL Chalmers","year":"2010","unstructured":"Chalmers RL, Begley CG, Caffery B (2010) Validation of the 5-Item Dry Eye Questionnaire (DEQ-5): discrimination across self-assessed severity and aqueous tear deficient dry eye diagnoses. Contact Lens Anterio 33(2):55\u201360","journal-title":"Contact Lens Anterio"},{"issue":"5","key":"608_CR31","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1001\/archopht.118.5.615","volume":"118","author":"RM Schiffman","year":"2000","unstructured":"Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL (2000) Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol 118(5):615\u2013621","journal-title":"Arch Ophthalmol"},{"key":"608_CR32","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1186\/1477-7525-9-111","volume":"9","author":"L Abetz","year":"2011","unstructured":"Abetz L, Rajagopalan K, Mertzanis P, Begley C, Barnes R, Chalmers R (2011) Development and validation of the impact of dry eye on everyday life (IDEEL) questionnaire, a patient-reported outcomes (PRO) measure for the assessment of the burden of dry eye on patients. Health Qual Life Out 9:111","journal-title":"Health Qual Life Out"},{"issue":"1","key":"608_CR33","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1136\/ard.57.1.20","volume":"57","author":"EM Hay","year":"1998","unstructured":"Hay EM, Thomas E, Pal B, Hajeer A, Chambers H, Silman AJ (1998) Weak association between subjective symptoms or and objective testing for dry eyes and dry mouth: results from a population based study. Ann Rheum Dis 57(1):20\u201324","journal-title":"Ann Rheum Dis"},{"issue":"3","key":"608_CR34","doi-asserted-by":"publisher","first-page":"A58","DOI":"10.1016\/j.jval.2011.02.331","volume":"14","author":"ME Johnson","year":"2011","unstructured":"Johnson ME, Ruiz WM, Li JZ (2011) PSS29 development of the modified ocular comfort index (MOCI). Value Health 14(3):A58","journal-title":"Value Health"},{"issue":"2","key":"608_CR35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0172056","volume":"12","author":"A Lackner","year":"2017","unstructured":"Lackner A, Ficjan A, Stradner MH, Hermann J, Unger J, Stamm T, Stummvoll G, D\u00fcr M, Graninger W, Dejaco C (2017) It\u2019s more than dryness and fatigue: the patient perspective on health-related quality of life in Primary Sj\u00f6gren\u2019s Syndrome: a qualitative study. PLoS ONE 12(2):e0172056","journal-title":"PLoS ONE"},{"issue":"10","key":"608_CR36","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1136\/bjophthalmol-2018-312581","volume":"103","author":"L Marc","year":"2019","unstructured":"Marc L, Tristan B, Serge D (2019) Classifying signs and symptoms of dry eye disease according to underlying mechanism via the Delphi method: the DIDACTIC study. Br J Ophthalmol 103(10):1475","journal-title":"Br J Ophthalmol"},{"key":"608_CR37","doi-asserted-by":"crossref","unstructured":"Nichols KK, Nichols JJ, Mph MS, Mitchell GL (2004) The lack of association between signs and symptoms in patients with dry eye disease. Cornea 23(8)","DOI":"10.1097\/01.ico.0000133997.07144.9e"},{"issue":"10","key":"608_CR38","doi-asserted-by":"publisher","first-page":"1170","DOI":"10.1001\/jamaophthalmol.2018.3352","volume":"136","author":"IJ Saldanha","year":"2018","unstructured":"Saldanha IJ, Petris R, Han G, Dickersin K, Akpek EK (2018) Research questions and outcomes prioritized by patients with dry eye. JAMA Ophthalmol 136(10):1170\u20131179","journal-title":"JAMA Ophthalmol"},{"issue":"10","key":"608_CR39","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0187272","volume":"12","author":"RJ Stack","year":"2017","unstructured":"Stack RJ, Southworth S, Fisher BA, Barone F, Buckley CD, Rauz S, Bowman S (2017) A qualitative exploration of physical, mental and ocular fatigue in patients with primary Sj\u00f6gren\u2019s Syndrome. PLoS ONE 12(10):e0187272","journal-title":"PLoS ONE"},{"key":"608_CR40","unstructured":"Gransnet Forums. https:\/\/www.gransnet.com\/forums\/health\/1230783-Dry-Eye-Syndrome. Accessed 3 July 2020"},{"key":"608_CR41","unstructured":"Patients like me. https:\/\/www.patientslikeme.com\/symptoms\/dry-eyes. Accessed 13 July 2020"},{"key":"608_CR42","unstructured":"Dry eye disease. The Dry Eye Zone Forums. http:\/\/forum.dryeyezone.com\/search?q=dry+eye+disease&searchJSON=%7B%22keywords%22%3A%22dry+eye+disease%22%7D. Accessed 22 July 2020"},{"key":"608_CR43","unstructured":"MGD. The Dry Eye Zone Forums. http:\/\/forum.dryeyezone.com\/search?q=MGD&searchJSON=%7B%22keywords%22%3A%22MGD%22%7D. Accessed 30 July 2020"},{"key":"608_CR44","unstructured":"Patients like me. https:\/\/www.patientslikeme.com\/conditions\/sjogren-s-syndrome. Accessed 30 July 2020"},{"key":"608_CR45","unstructured":"Sjogren's blog. Facebook. https:\/\/www.facebook.com\/Sjogrens-blog-233053606739810\/. Accessed 13 August 2020"},{"issue":"1, Supplement","key":"608_CR46","doi-asserted-by":"publisher","first-page":"S245","DOI":"10.1016\/j.jval.2021.11.1196","volume":"25","author":"B Sloesen","year":"2022","unstructured":"Sloesen B, Walsh O, O\u2019Brien P, Bentley S, Hodson N, Finbow C, Findley A, Montecchi-Palmer M, Haque S (2022) Qualitative research exploring the patient experience of symptoms and health-related quality of life impacts in chronic ocular surface pain. Value Health 25(1, Supplement):S245","journal-title":"Value Health"},{"key":"608_CR47","doi-asserted-by":"publisher","DOI":"10.4135\/9781412983655","volume-title":"Cognitive interviewing","author":"G Willis","year":"2005","unstructured":"Willis G (2005) Cognitive interviewing. Thousand Oaks, California"},{"key":"608_CR48","volume-title":"Transforming qualitative information: thematic analysis and code development","author":"RE Boyatzis","year":"1998","unstructured":"Boyatzis RE (1998) Transforming qualitative information: thematic analysis and code development. Thousand Oaks, California"},{"key":"608_CR49","first-page":"93","volume-title":"Doing qualitative research: research methods for primary care","author":"BF Crabtree","year":"1992","unstructured":"Crabtree BF, Miller WF (1992) A template approach to text analysis: developing and using codebooks. In: Crabtree BF, Miller WF (eds) Doing qualitative research: research methods for primary care, vol 3. Thousand Oaks, California, pp 93\u2013109"},{"issue":"10","key":"608_CR50","doi-asserted-by":"publisher","first-page":"1229","DOI":"10.1080\/08870440903194015","volume":"25","author":"JJ Francis","year":"2010","unstructured":"Francis JJ, Johnston M, Robertson C, Glidewell L, Entwistle V, Eccles MP, Grimshaw JM (2010) What is an adequate sample size? Operationalising data saturation for theory-based interview studies. Psychol Health 25(10):1229\u20131245","journal-title":"Psychol Health"},{"issue":"1","key":"608_CR51","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1177\/1525822X05279903","volume":"18","author":"G Guest","year":"2006","unstructured":"Guest G, Bunce A, Johnson L (2006) How many interviews are enough? An experiment with data saturation and variability. Field Method 18(1):59\u201382","journal-title":"Field Method"}],"container-title":["Journal of Patient-Reported Outcomes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41687-023-00608-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s41687-023-00608-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s41687-023-00608-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,7,5]],"date-time":"2023-07-05T12:08:09Z","timestamp":1688558889000},"score":1,"resource":{"primary":{"URL":"https:\/\/jpro.springeropen.com\/articles\/10.1186\/s41687-023-00608-5"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,7,5]]},"references-count":51,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["608"],"URL":"https:\/\/doi.org\/10.1186\/s41687-023-00608-5","relation":{},"ISSN":["2509-8020"],"issn-type":[{"value":"2509-8020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,7,5]]},"assertion":[{"value":"1 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 June 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 July 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved and overseen by the Western Copernicus Group Independent Review Board (WCG IRB), a centralized ethics review committee in the US (reference: 20204523). Informed consent was obtained from all participants prior to conducting interviews and relevant study activities.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"BS, OW and CN are employees of Novartis Pharma AG. AY, KF, NH, SB are employees of Adelphi Values which received funding from Novartis Pharma AG to complete this work. PB and GS are employees at Novartis Ireland Limited, Dublin and Novartis Healthcare Private Limited, Hyderabad, India respectively.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"64"}}